| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer
2 companies
Wambeke David J. is a Chief Business Officer at NeuroOne Medical Technologies Corporation with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $8.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2026 | NMTC Neuroone Medical Technologies Corporation | Chief Business Officer | Buy | 1,000,000 | $0.67 | $670,400.00 | New | - | - | |
| Nov 16, 2023 | DMAC Diamedica Therapeutics Inc. | Chief Business Officer | Buy | 20,000 | $2.46 | $49,200.00 | +3.9% | +23.9% | +68.5% | |
| Jun 23, 2023 | DMAC Diamedica Therapeutics Inc. | Chief Business Officer | Buy | 38,364 | $3.91 | $150,003.24 | +8.2% | -29.4% | -49.2% | |
| Apr 10, 2023 | DMAC Diamedica Therapeutics Inc. | Chief Business Officer | Buy | 468,750 | $1.60 | $750,000.00 | New | +135.7% | +72.6% |